2-AMINO-4-(4-FLUOROBENZYLAMINO)-1-ETHOXYCARBONYL-AMINOBENZENE AS ACTIVE COMPONENT OF MEDICINAL AGENT FOR PROPHYLAXIS AND TREATMENT OF RESULTS OF ACUTE AND CHRONIC CEREBRAL INSUFFICIENCY AND NEURODEGENERATIVE DISEASES ALSO (VARIANTS)

FIELD: medicine, neurology. SUBSTANCE: invention relates to treatment of acute and chronic cerebral insufficiency and neurodegenerative diseases also. For this purpose retigabin is used that is activator of potassium channels. Invention ensures to enhance effectiveness of indicated diseases due to u...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BARCH RENI, RUNDFEL'DT KRIS, TOBER KRISTINA, ROSTOK ANGELIKA
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, neurology. SUBSTANCE: invention relates to treatment of acute and chronic cerebral insufficiency and neurodegenerative diseases also. For this purpose retigabin is used that is activator of potassium channels. Invention ensures to enhance effectiveness of indicated diseases due to use of preparation eliciting expressed neuroprotective properties. EFFECT: enhanced effectiveness of treatment. 3 cl, 1 tbl